-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Innovative Fellowship Curriculum

Program: Special-Interest Sessions
Session: Training Program Directors Workshop
Hematology Disease Topics & Pathways:
Education
Friday, December 6, 2024, 9:00 AM-12:00 PM

Layla N Van Doren, MD, MBA

Section of Hematology, Division of Medicine, Yale School of Medicine, New Haven, CT

Disclosures: Van Doren: Sanofi: Ended employment in the past 24 months, Speakers Bureau; Pharmacosmos, Inc: Consultancy, Honoraria; Sobi: Ended employment in the past 24 months, Speakers Bureau; Pfizer/GBT: Ended employment in the past 24 months, Speakers Bureau; Daiichi Sankyo: Ended employment in the past 24 months, Speakers Bureau.